Along with receiving a diagnosis of prostate cancer, comes new medical terminology that is likely unfamiliar to most men. One of the terms a man will hear is what is called a Gleason score. In 1966, a grading system for prostate cancer was developed by Dr. Donald Gleason. The Gleason score, still bearing his name today, is a system used to grade the aggressiveness of prostate cancer tissue.
Read MoreAccording to a recent study in the journal of BMC Urology, a higher percentage of men participating in high levels of physical activity 5-7 times per week preoperatively had a reduced need for sick leave after radical prostatectomy.
Read MoreActive Surveillance/Watchful Waiting. These are not types of treatment, but ways to monitor prostate cancer when it is very low-risk or slow growing. During active surveillance or watchful waiting, your doctor will keep track of the prostate cancer using various tests including a PSA blood test, digital rectal exam, and ultrasound. If the prostate cancer becomes more aggressive, your doctor may recommend other treatment options.
Read MoreWhat is Cyberknife? Cyberknife is a form of stereotactic body radiation therapy (SBRT) and robotic-assisted radiosurgery (not actual surgery) that utilizes a computerized robot to automatically deliver high doses of radiation to the prostate gland. Fiducials are implanted into the body so that the Cyberknife machine can adjust to movement during each treatment.
Read MoreA new study from Australia suggests that robotic-assisted laparoscopic radical prostatectomy is more effective at preserving erectile function and urinary continence than a laparoscopic radical prostatectomy for treating localized prostate cancer. The study was recently published as a meta-analysis in Urologia Internationalis. The study was conducted by researchers at Monash University in Melbourne, Australia. It involved two randomized controlled trials and included a total of 232 patients in which each of their surgical approaches were compared.
Read MoreIf you’re one of the 230,000 men diagnosed with prostate cancer every year, you’re probably dealing with a dilemma of which treatment option to choose. Your doctor has likely spoken with you about radiation and surgery, but how do you choose?
Read MoreProstate cancer affects almost 234,000 men each year. Here are 11 treatment options to educate men diagnosed with prostate cancer.
Read MoreThe U.S. Preventive Services Task Force recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011.
Read MoreWho's at risk for prostate cancer? Knowing your risk factors such as lifestyle habits and family history can save your life. Knowledge is power. Here's what men and women need to know.
Read MoreNearly 3 million men are living with prostate cancer in the U.S. New findings are showing a major correlation between what a man eats and the difference in how long he'll live with the cancer. An unhealthy western diet may contribute to more aggressive prostate cancer.
Read MoreA new study from suggests that statins either alone or in combination with metformin may reduce the risk of dying from prostate cancer. The study’s findings were presented at the American Society of Clinical Oncology annual meeting in Chicago. The study was carried out by Grace L. Lu-Yao, PhD, an epidemiologist at the Rutgers Cancer Institute of New Jersey in New Brunswick.
Read MoreA new study from Duke University Medical Center published in the journal, BMC Medicine, showed that what you eat can influence the risk of prostate cancer. Here's what men need to know.
Read More
